Table 2 Landmark survival for all indications
From: Overall survival of individuals with metastatic cancer in Sweden: a nationwide study
Survival | Metastatic breast cancer | Metastatic non-small cell lung cancer | Metastatic colorectal cancer | Metastatic ovarian cancer | Metastatic malignant melanoma |
|---|---|---|---|---|---|
Median survival (months, 95% CI) | 20 (19.4, 20.6) | 5.18 (5.1, 5.3) | 12.8 (12.6, 13.1) | 23.4 (22.0, 24.9) | 7.4 (6.8, 7.9) |
1-year survival (%, 95% CI) | 61 (60.4, 61.9) | 25.4 (24.8, 26.0) | 51.8 (51.1, 52.4) | 69 (66.9,71.1) | 38.9 (37.4, 40.4) |
5-year survival (%, 95% CI) | 21.6 (20.9, 22.3) | 3.2 (3.0, 3.6) | 15.1 (15.0, 16.0) | 20.3 (18.3, 22.5) | 15.6 (14.4, 16.9) |
10-year survival (%, 95% CI) | 10 (9.4, 10.7) | 1.7 (1.4, 2.0) | 10 (9.5, 10.5) | 10.3 (8.54, 12.5) | 10.6 (9.4, 12.1) |